BIOLASE

NASDAQ BIOL
$0.19 0.0000 0.0000%
Today share price
สหรัฐอเมริกา
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Показатель: 23 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

3.43M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

11.79M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.

1.61
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.

17.84M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.

-82.89 %

Upcoming events BIOLASE

All events
No upcoming events scheduled

Stock chart BIOLASE

Stock analysis BIOLASE

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

-0.16 53.92
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

-13.87 18.69
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

-0.85 38.72
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

-0.60 0.81
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

1,099.69 18.00

Price change BIOLASE per year

0.26$ 1.51$
Min Max

Summary analysis BIOLASE

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure BIOLASE

Revenue and net income BIOLASE

All parameters

Stock news BIOLASE

All news

Biolase Shares Plummet After Offering Prices

Biolase Shares Plummet After Offering Prices

Biolase to Cut 20% of Workforce

Biolase to Cut 20% of Workforce

Biolase Hits 52-Week Low of 7 Cents After Offering Prices

Biolase Hits 52-Week Low of 7 Cents After Offering Prices

Biolase stock price target cut to $11 from $14 at Ascendiant Capital

Biolase Shares Edge Down 5.9% Despite 2023 Revenue Guidance Above Estimates

Biolase Shares Edge Down 5.9% Despite 2023 Revenue Guidance Above Estimates

Biolase Names Jennifer Bright Finance Chief

Biolase Names Jennifer Bright Finance Chief

BIOLASE Shares Down 16.5% After Direct Offering Prices

BIOLASE Shares Down 16.5% After Direct Offering Prices

Biolase Reports 2Q Results, Shares Rise 23% After Hours

About company BIOLASE

BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, such as cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode laser systems for soft tissue, pain therapy, teeth whitening, and cosmetic procedures; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces, and teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Foothill Ranch, California.
Address:
27042 Towne Centre Drive, Foothill Ranch, CA, United States, 92610-2811
Company name: BIOLASE
Issuer ticker: BIOL
ISIN: US0909112072
Country: สหรัฐอเมริกา
Exchange: NASDAQ
Currency: $
IPO date: 1992-11-13
Sector: Healthcare
Industry: Health Care Equipment & Supplies
Site: https://www.biolase.com

On which stock exchange are BIOLASE (BIOL) stocks traded?

BIOLASE (BIOL) stocks are traded on NASDAQ.

What is the ticker of BIOLASE stocks (BIOL)?

The stock ticker of BIOLASE’s stocks or in other words, the code is BIOL. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does BIOLASE (BIOL) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, BIOLASE (BIOL) belongs to the «Healthcare» sector and the «Health Care Equipment & Supplies» industry.

In what currency are BIOLASE (BIOL) stocks traded?

BIOLASE (BIOL) stocks are traded on the NASDAQ exchange in dollars.

What is the price of BIOLASE (BIOL) stocks today?

The current price of BIOLASE stocks on 24.05.2024 is 0.192 dollars. per share.

What is the dynamics of BIOLASE (BIOL) stocks from the beginning of the year?

BIOLASE (BIOL) quotes have increased by -82.55% from the beginning of the year up to 0.192 dollars. per 1 stocks.

How much did BIOLASE (BIOL) stocks increase in мае 2024?

This month BIOLASE (BIOL) quotes have increased by 32.78% to 0.192 dollars. per share.

How much are BIOLASE (BIOL) stocks worth?

Today, on October, 24.05.2024 BIOLASE’s (BIOL) stocks cost 0.192 dollars..

What is the market capitalization of BIOLASE (BIOL)?

Capitalization is the market value of BIOLASE (BIOL) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 24.05.2024, the market capitalization of BIOLASE (BIOL) is estimated at about 3425664 dollars.